Level Biotechnology Inc. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 159.053 million compared to TWD 119.507 million a year ago. Operating income was TWD 12.357 million compared to TWD 9.476 million a year ago. Net income was TWD 9.687 million compared to TWD 8.713 million a year ago. Basic earnings per share was TWD 0.3 compared to TWD 0.27 a year ago. For the nine months, sales was TWD 435.790 million compared to TWD 394.718 million a year ago. Operating income was TWD 30.345 million compared to TWD 53.042 million a year ago. Net income was TWD 25.725 million compared to TWD 47.642 million a year ago. Basic earnings per share was TWD 0.79 compared to TWD 1.47 a year ago. Diluted earnings per share was TWD 0.79 compared to TWD 1.46 a year ago.